Aethlon Medical Plunges 17.35% on Stock Sale Filing

Aethlon Medical's stock experienced a significant drop of 17.35% in pre-market trading on August 22, 2025, marking a notable decline for the company.

Aethlon Medical recently filed to sell common stock and warrants, which could potentially impact its stock price. This move is part of the company's broader strategy to raise capital and support its ongoing operations and strategic initiatives.

The company has also received a significant investment injection of $6 million from David E. Lazar, which is expected to bolster its financial position and support its future growth plans.